Workshop will concentrate on latest advances in non-invasive imaging technologies.
The EU-funded project TRANSVAC2 and the “Infectious Diseases Models for Innovative Therapies” (IDMIT) are pleased to invite you to a TRANSVAC workshop on “In vivo imaging of host response to vaccines and infections” on 29 March 2019 at the IDMIT research infrastructure at the CEA center of Fontenay-aux-Roses (France). The workshop concentrates on latest advances in new technologies for imaging in living individuals.
This workshop is aimed to present the following topics:
1) Kinetics of vaccines distribution and persistence,
2) Pathogen penetration and dissemination,
3) Host response to vaccines and pathogens exposure.
The workshop will be focused on implication of these approaches for preclinical research and translational medicine. International experts of diverse expertise on fluorescent based technologies as well as whole body Positron Emission Tomography–Computed Tomography (PET-CT) and Magnetic Resonance Imaging (MRI) technologies will be invited to describe and comment the application of these tools for vaccine research and development.
Four thematic sessions will be offered:
In vivo imaging of host response: Visualizing host cells in living animals
Dynamics of pathogen and vaccine antigen distribution and/or dissemination: Local interactions and micro-environment
Whole body imaging of host/pathogen & antigen interactions
Transfer to clinical investigation and practice
Roundtables will be held to discuss the needs and opportunities for imaging in vaccine development.
Registration is free and compulsory until 1 March 2019.
For more information, please contact Isabelle Mangeot (isabelle.mangeot@cea.fr)
Due to the fact that there are limited places available and participation will be on a “first come first served basis”, registration will close when maximum number of participants will be reached. Find all information and the preliminary program on the TRANSVAC2 (http://transvac.org/) and IDMIT website (http://www.idmitcenter.fr/ ).
Comentarios